XML 52 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Shareholders’ Deficit (Tables)
12 Months Ended
Dec. 28, 2019
Shareholders Equity [Abstract]  
Schedule of Stock-Based Compensation Expense

Total stock-based compensation expense was as follows (in thousands):

 

 

2019

 

 

2018

 

 

2017

 

Stock awards

 

$

14,265

 

 

$

8,930

 

 

$

13,419

 

Stock options

 

 

2,392

 

 

 

2,482

 

 

 

2,344

 

Total stock-based compensation expense(1)

 

 

16,657

 

 

 

11,412

 

 

 

15,763

 

Income tax benefit

 

 

3,998

 

 

 

2,750

 

 

 

5,249

 

Total stock-based compensation expense, net of tax

 

$

12,659

 

 

$

8,662

 

 

$

10,514

 

 

(1)

Decrease in 2018 stock-based compensation expense reflects the cumulative impact of the change in the expected achievements of certain performance targets.

  

Summary of Stock Option Activity

  

A summary of our stock option activity was as follows (in thousands, except per share amounts and years):

 

 

Stock

Options

 

 

Weighted-

Average

Exercise

Price per

Share

 

 

Weighted-

Average

Remaining

Contractual

Term (years)

 

 

Aggregate

Intrinsic

Value (1)

 

Balance at December 29, 2018

 

 

1,322

 

 

$

22.64

 

 

 

5.9

 

 

$

13,009

 

Granted

 

 

141

 

 

 

45.27

 

 

 

 

 

 

 

 

 

Exercised

 

 

(381

)

 

 

18.88

 

 

 

 

 

 

 

 

 

Canceled/Forfeited

 

 

(14

)

 

 

30.13

 

 

 

 

 

 

 

 

 

Outstanding at December 28, 2019

 

 

1,068

 

 

$

26.87

 

 

 

6.0

 

 

$

24,274

 

Exercisable at December 28, 2019

 

 

772

 

 

$

22.88

 

 

 

5.1

 

 

$

20,612

 

Vested and expected to vest at December 28, 2019

 

 

1,046

 

 

$

26.70

 

 

 

6.0

 

 

$

23,940

 

 

(1)

Aggregate intrinsic value includes only those options where the current share price is equal to or greater than the share price on the date of grant.

 

Other Information Pertaining to Options

Other information pertaining to options was as follows (in thousands, except per share amounts):

 

 

2019

 

 

2018

 

 

2017

 

Weighted-average grant date fair value of stock options granted

 

$

18.97

 

 

$

13.96

 

 

$

10.33

 

Total intrinsic value (at exercise) of stock options exercised

 

$

9,636

 

 

$

3,459

 

 

$

3,586

 

 

Assumptions Used to Calculate Fair Value of Options Granted Using Black-Scholes-Merton Option-Pricing Model

The assumptions used to calculate the fair value of options granted using the Black-Scholes-Merton option-pricing model were as follows:

Valuation Assumptions

 

2019

 

 

2018

 

 

2017

 

Expected dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

Expected volatility

 

 

43

%

 

 

43

%

 

 

46

%

Risk-free interest rate

 

 

2.2

%

 

 

2.7

%

 

 

2.0

%

Expected term (in years)

 

 

5.4

 

 

 

5.0

 

 

 

5.1

 

 

Stock Award Activity

Stock award activity was as follows (in thousands, except per share amounts):

 

 

Time-

Based

Stock

Awards

 

 

Weighted-Average

Grant Date

Fair Value

 

 

Performance- and

Market-Based

Stock Awards

 

 

Weighted-Average

Grant Date

Fair Value

 

Outstanding at December 29, 2018

 

 

383

 

 

$

28.66

 

 

 

1,061

 

 

$

23.91

 

Granted

 

 

172

 

 

 

44.60

 

 

 

168

 

 

 

46.70

 

Vested

 

 

(192

)

 

 

25.91

 

 

 

(304

)

 

 

19.50

 

Canceled/Forfeited

 

 

(33

)

 

 

35.26

 

 

 

(333

)

 

 

22.75

 

Outstanding at December 28, 2019

 

 

330

 

 

$

38.09

 

 

 

592

 

 

$

33.30

 

 

Assumptions Used to Calculate Fair Value of Performance-based Stock Awards Using Monte Carlo Simulation Model The assumptions used to calculate the fair value of the 2018 and 2017 performance-based stock awards with a market condition, using the Monte Carlo simulation model, were as follows:

 

Valuation Assumptions

 

2019

 

2018

 

 

2017

 

Expected dividend yield

 

NA

 

 

0

%

 

 

0

%

Expected volatility

 

NA

 

 

43

%

 

 

46

%

Risk-free interest rate

 

NA

 

 

2.6

%

 

 

1.5

%

 

Schedule of Repurchase of Common Stock

Repurchases of our common stock were as follows (in thousands):

 

 

2019

 

 

2018

 

 

2017

 

Amount repurchased under Board-approved share repurchase program

 

$

145,900

 

 

$

279,101

 

 

$

150,000

 

Amount repurchased in connection with the vesting of employee restricted

   stock grants

 

 

9,673

 

 

 

3,344

 

 

 

5,245

 

Total amount repurchased (based on trade dates)

 

$

155,573

 

 

$

282,445

 

 

$

155,245

 

 

Net Income per Common Share

The components of basic and diluted net income per share were as follows (in thousands, except per share amounts):

 

 

2019

 

 

2018

 

 

2017

 

Net income

 

$

81,845

 

 

$

69,539

 

 

$

65,077

 

Reconciliation of weighted-average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted-average shares outstanding

 

 

29,472

 

 

 

35,256

 

 

 

41,212

 

Dilutive effect of stock-based awards

 

 

883

 

 

 

909

 

 

 

873

 

Diluted weighted-average shares outstanding

 

 

30,355

 

 

 

36,165

 

 

 

42,085

 

Net income per share – basic

 

$

2.78

 

 

$

1.97

 

 

$

1.58

 

Net income per share – diluted

 

$

2.70

 

 

$

1.92

 

 

$

1.55